AOBLX
Price
$10.98
Change
+$0.03 (+0.27%)
Updated
Mar 7 closing price
Net Assets
401.62M
RLBCX
Price
$33.88
Change
-$0.55 (-1.60%)
Updated
Mar 10 closing price
Net Assets
237.28B
Ad is loading...

AOBLX vs RLBCX

Header iconAOBLX vs RLBCX Comparison
Open Charts AOBLX vs RLBCXBanner chart's image
Pioneer Balanced ESG A
Price$10.98
Change+$0.03 (+0.27%)
VolumeN/A
Net Assets401.62M
American Funds American Balanced R3
Price$33.88
Change-$0.55 (-1.60%)
VolumeN/A
Net Assets237.28B
AOBLX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AOBLX vs. RLBCX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AOBLX is a StrongBuy and RLBCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 237B vs. AOBLX (402M). AOBLX pays higher dividends than RLBCX: AOBLX (1.87) vs RLBCX (1.65). AOBLX was incepted earlier than RLBCX: AOBLX (33 years) vs RLBCX (23 years). AOBLX (0.94) is less costly to investors than RLBCX (0.89). RLBCX is a more actively managed with annual turnover of: 171.00 vs. AOBLX (33.00). RLBCX has a lower initial minimum investment than AOBLX: RLBCX (250) vs AOBLX (1000). RLBCX annual gain was more profitable for investors over the last year : 4.82 vs. AOBLX (3.71). RLBCX return over 5 years is better than : 32.76 vs. AOBLX (28.69).
AOBLXRLBCXAOBLX / RLBCX
Total Expense Ratio0.940.89106%
Annual Report Gross Expense Ratio0.940.89106%
Fund Existence33 years23 years-
Gain YTD-0.1820.938-19%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets402M237B0%
Annual Yield % from dividends1.871.65114%
Returns for 1 year3.714.8277%
Returns for 3 years15.6516.5295%
Returns for 5 years28.6932.7688%
Returns for 10 years39.4750.7478%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APTO3.170.22
+7.46%
Aptose Biosciences. Inc.
CRL175.926.65
+3.93%
Charles River Laboratories International
CFB15.99N/A
N/A
CrossFirst Bankshares
XENE36.50-0.78
-2.09%
Xenon Pharmaceuticals
ALEC1.44-0.14
-8.86%
Alector